Details for Patent: 11,351,317

✉ Email this page to a colleague

Patent 11,351,317 protects PROAIR DIGIHALER, AIRDUO DIGIHALER, and ARMONAIR DIGIHALER, and is included in three NDAs.

Protection for AIRDUO DIGIHALER has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has twenty-eight patent family members in thirteen countries.

Patent landscape, scope, and claims:

Title:	Drug delivery device with electronics
Abstract:	A device for delivering medication to a user may include a main body, an electronics module, and a slider. The main body may include a mouthpiece, a medication reservoir, and a mouthpiece cover, where the mouthpiece cover may be hinged to the main body. The electronics module may include a communication circuit, a pressure sensor, and a switch. The slider may be configured to engage the switch when the mouthpiece cover moves from a closed position to an open position. The switch may be configured to switch the electronics module from an off state or a sleep state to an active state. The electronics module may be configured to never return to the off state after the mouthpiece cover is moved to expose the mouthpiece for the first time by the user.
Inventor(s):	Calderon Oliveras; Enrique (Waterford, IE), Lewis; Carl L. (Cambridgeshire, GB), Cotton; Symon D'Oyly (Cambridge, GB), Gardner; Steven D. (Peterborough, GB), Kivlin; Robert O. (Cambridge, GB)
Assignee:	Norton (Waterford) Limited (Waterford, IE)
Application Number:	16/148,046
Patent Claim Types: see list of patent claims	Use; Delivery; Device;
More… ↓ ⤷ Subscribe

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Teva Branded Pharm	PROAIR DIGIHALER	albuterol sulfate	POWDER, METERED;INHALATION	205636-002	Dec 21, 2018		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe	Y				⤷ Subscribe
Teva Pharm	AIRDUO DIGIHALER	fluticasone propionate; salmeterol xinafoate	POWDER;INHALATION	208799-004	Jul 12, 2019		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe			Y		⤷ Subscribe
Teva Pharm	AIRDUO DIGIHALER	fluticasone propionate; salmeterol xinafoate	POWDER;INHALATION	208799-005	Jul 12, 2019		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe			Y		⤷ Subscribe
Teva Pharm	AIRDUO DIGIHALER	fluticasone propionate; salmeterol xinafoate	POWDER;INHALATION	208799-006	Jul 12, 2019		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe			Y		⤷ Subscribe
Teva Pharm	ARMONAIR DIGIHALER	fluticasone propionate	POWDER;INHALATION	208798-008	Apr 8, 2022		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe			Y		⤷ Subscribe
Teva Pharm	ARMONAIR DIGIHALER	fluticasone propionate	POWDER;INHALATION	208798-004	Feb 20, 2020		DISCN	Yes	No	⤷ Subscribe	⤷ Subscribe			Y		⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2017361878	⤷ Subscribe
Australia	2022263489	⤷ Subscribe
Canada	3043965	⤷ Subscribe
China	110167619	⤷ Subscribe
China	114177442	⤷ Subscribe
Denmark	3471805	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration